This Government Contract opportunity from Department Of Defense was posted on September 27, 2008. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

A--Adenoviral Dengue Vaccine

Awarded

W911QY08RADVFederal

Submission Closed09/22/2008, 12:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541711

New

Federal

MANAGE AND OPERATE THE NATIONAL RENEWABLE ENERGY LABORATORYThe Department of Energy, through the Golden Field Office, is forecasting a contract to manage and operate the National Renewable Energy Laboratory located in Colorado. This initiative falls under NAICS code 541711 and is currently associated with the incumbent contractor, Alliance for Energy Innovation, LLC. The opportunity is listed as a forecast with a posted date of October 25, 2026. Yolanda Dixon serves as the Small Business Program Manager and primary point of contact for this requirement.

POSTED

DEADLINE

Research Subaward / Collaborative Research PartnerThis subcontract establishes a collaborative research partnership to support prime contractors on research projects funded by the National Science Foundation and UK Research and Innovation, specifically under the Arts and Humanities Research Council. The selected partner is responsible for executing specialized research tasks, including data collection and analysis, following project-defined methodologies to solve specific research challenges and support planned outputs. Key deliverables include the provision of research data, detailed analysis reports, and contributions to final publications. To ensure compliance, all work must adhere to the NSF Grant Policy Manual and established UKRI funding norms. The engagement is categorized under NAICS code 541711, focusing on research and experimental development in the natural sciences and engineering.

Arts and Humanities Research Council (AHRC)

POSTED

DEADLINE

Research Collaboration and Laboratory AnalysisThe Research Collaboration and Laboratory Analysis subcontract is issued by the National Institute of Food and Agriculture under the Department of Agriculture. This agreement focuses on supporting grant recipients of the USDA-NIFA 1890 Capacity Building Grant Program through the execution of research tasks, data collection, and laboratory analysis. The scope of work includes conducting field trials and laboratory testing to meet specific scientific objectives, with required deliverables consisting of research data sets, technical reports, and peer-reviewed publications. Classified under NAICS code 541711, the opportunity was posted on September 3, 2026, with a response deadline of November 4, 2026. This subcontract is designed to provide essential technical and analytical support to ensure the successful completion of research goals within the specified grant program.

National Institute Of Food And Agriculture

POSTED

DEADLINE

Novel In-Situ Binder Chemistry DevelopmentThe NASA SBIR/STTR Program is seeking a subcontractor for the development of a novel in-situ binder chemistry designed for use on the Moon or Mars. The primary objective of this project is to create a binder sourced entirely from lunar or Martian regolith that can cure without the need for external energy input. The scope of work encompasses the initial formulation, lab-scale testing, and subsequent optimization of the chemistry to ensure viability for extraterrestrial construction. This opportunity is designated as a Total Small Business Set-Aside under the SBIR/STTR mandate, specifically for firms with fewer than 500 employees. The work will be performed at the Kennedy Space Center, falling under NAICS code 541711 for research and development in biotechnology. The solicitation was posted on August 20, 2026, as part of NASA's efforts to advance sustainable infrastructure capabilities for deep space exploration.

NASA SBIR/STTR Program

POSTED

DEADLINE

High-Throughput Serology Assay DevelopmentThe contract requires the design, validation, and delivery of a high-throughput serology platform intended to match or surpass the performance of the current hemagglutination inhibition (HAI) assay used for influenza surveillance. The platform must be scalable and robust enough to support large-scale, rapid serological testing, ensuring accurate and consistent data collection for public health monitoring. Development must adhere to stringent performance benchmarks, with a focus on improving throughput, precision, and reproducibility across diverse influenza strains and sample types. This is a subcontract under the Department of Defense’s FA9000 AFGPO program, with performance centered at DWG. The North American Industry Classification System code 541711 indicates it falls under research and development in the physical, engineering, and life sciences. The solicitation was posted on June 15, 2026, and the work is expected to advance the DoD’s capability in infectious disease surveillance by replacing aging laboratory methods with a next-generation automated system. While no set-aside or point of contact details are provided, the project’s success is critical to maintaining national-level preparedness for seasonal and pandemic influenza threats.

POSTED

DEADLINE

Engineering & Scientific Research SupportThe contract entails providing engineering analysis, research and development, and technical support specifically focused on F-15 aircraft systems, encompassing avionics, propulsion, and weapons integration. The work involves activities such as modeling, simulation, and the formulation of test plans to support enhancements and maintenance of these complex systems. Issued by the Department of Defense under the NAICS code 541711, this subcontract titled "Engineering & Scientific Research Support" is designed to advance the technical capabilities and reliability of the F-15 platform. While certain logistical details like the exact place of performance and point of contact are not specified, the contract underscores a commitment to rigorous scientific and engineering efforts to ensure mission readiness and technological superiority for this key military asset.

FA8622 Aflcmc Azs Epass

POSTED

DEADLINE

Technical Research and Analysis (Science & Technology Focus)This contract involves conducting advanced technical research across physical, engineering, and life sciences disciplines to support innovation and technology development within the defense sector. It is a subcontract opportunity issued by the Department of Defense through Washington Headquarters Services, aimed at advancing scientific and technological capabilities that bolster defense-related projects and initiatives. Designated as a Total Small Business Set-Aside under SBA regulations, the contract falls under NAICS code 541711, which pertains to research and development in the physical, engineering, and life sciences. The work is to be performed in Washington, reflecting a focus on high-impact, cutting-edge research that addresses critical defense challenges. This opportunity emphasizes the Department of Defense's commitment to engaging small businesses in strategic research efforts that drive forward defense technology and innovation.

Washington Headquarters Services

POSTED

DEADLINE

Vehicle Recompete: IGF::OT::IGF ID/IQ PARENT AWARD FOR PHARMACOLOGY AND TOXICOLOGY FOR… — INDEFINITE DELIVERY / INDEFINITE QUANTITY NIHNINDS1601This Indefinite Delivery/Indefinite Quantity parent award supports the Pharmacology and Toxicology for Therapeutics Program under the National Institutes of Health. The vehicle, identified by solicitation NIHNINDS1601, has an ordering period that extends through September 12, 2027. It is currently classified as a full recompete and is associated with two primary awards, HHSN271201600006I and HHSN271201600007I. There are currently 18 active task orders with a total combined value of over 18.7 million dollars. SRI International is the dominant incumbent, holding 15 orders totaling approximately 17.1 million dollars, with significant funding dedicated to continuous rodent and non-rodent pharmacokinetic assessments and GLP toxicology studies. Southern Research Institute holds the remaining three orders, valued at approximately 1.66 million dollars.

National Institutes of Health

POSTED

DEADLINE

Biotechnology and Life Sciences R&DThis subcontract, issued by the Department of Defense's AFRL Headquarters, focuses on biotechnology and life sciences research and development with an emphasis on defense-related applications. The scope involves advancing technologies such as bio-sensing, enhancing human performance, and developing medical countermeasures to support military readiness and resilience. The contract falls under the NAICS code 541711, which pertains to research and development in the physical, engineering, and life sciences. Although certain logistical details like specific location and points of contact are not provided, the work aims to contribute cutting-edge biotechnological innovations for national defense purposes. The solicitation was posted in January 2026, indicating a current opportunity for entities capable of delivering advanced R&D services in these specialized fields, collaborating closely with the Department of Defense to address evolving defense challenges through scientific and technological efforts.

FA8652 Afrl Hq Afrl/pk

POSTED

DEADLINE

Green Chemistry R&D SupportThe Green Chemistry R&D Support subcontract, issued by the California Department of Toxic Substances Control, focuses on advancing the safety of nail product formulations. The primary objective is to assist manufacturers in researching and developing safer alternatives through the application of green chemistry initiatives, scientific collaboration, and rigorous pilot testing. This initiative falls under NAICS code 541711, indicating a focus on research and development in the physical, engineering, and life sciences. The project was posted on December 23, 2025, and aims to reduce hazardous substances in consumer products through targeted technical support and innovation.

California Toxic Substances Control, Department of

POSTED

10 months ago

DEADLINE

N/A

AI Contract Overview

The U.S. Army Research, Development and Engineering Command (RDECOM) Natick Contracting Division, acting on behalf of the Naval Health Research Center, plans to negotiate and award a sole-source contract to GenPhar, Inc., located in Mount Pleasant, South Carolina. This decision is made under FAR 6.302-1 authority, recognizing GenPhar as the exclusive manufacturer and patent holder of a specialized dengue vaccine formulation utilizing a complex adenovirus vector. The vaccine, developed in collaboration with the Naval Medical Research Center over three years, is intended for use in human clinical trials and includes a mixture of two vaccine constructs that express antigens from all four dengue virus serotypes to maintain consistency with prior research batches. This procurement is not open for competition, and no solicitation document will be provided. However, firms confident in meeting the requirements may submit written notices and supporting documentation within fifteen days from the synopsis publication date to demonstrate their capability, though the government retains sole discretion in deciding whether to proceed with competition. The contract focuses on maintaining reproducibility of vaccine data aligned with ongoing studies, underscoring the unique nature of GenPhar's product. The synopsis deadline for responses is July 21, 2008, at 10:00 EST, and questions or submissions are directed to the designated Contract Specialist via email.

General Info

Sole-source contract to GenPhar for specialized dengue vaccine clinical trial use, no competition.

Agency

Department Of Defense → W6QK Acc-Apg Natick

Contract Value

$2,177,600

NAICS

541711 - Research and Development in Biotechnology

Place of Performance

MA, USA

Set-Aside

NONE

Awardee

GENPHAR INC

Award Issued Date

09/22/2008, 12:00:00 AM UTC

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded

PostedJun 10

special-notice

AwardedSep 22

Contract was awarded

Submission Closed

09/22/2008, 12:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → W6QK Acc-Apg Natick

ContactsNo contacts available

OfficeNATICK, MA, 01760-5011, USA

Organization / AgencyDepartment Of Defense → W6QK Acc-Apg Natick

Office AddressNATICK, MA, 01760-5011, USA

ContactsNo contact information available

Full Description

Under the authority of FAR 6.302-1, the U.S. Army, RDECOM, Natick Contracting Division, Kansas Street, Natick, MA, on behalf of the Naval Health Research Center, intends to negotiate and award a contract to GenPhar, Inc. of 600 Seacoast Parkway, Mount Pleasant, South Carolina. GenPhar, Inc. is the only producer and supplier of the dengue vaccine formulation based on a complex adenovirus vector, for use in a human clinical vaccine trial, which was developed in close collaboration with Naval Medical Research Center (NMRC) requirements over the last three years. GenPhar, Inc. currently holds the patent for the dengue vaccine. Requirements include, but not limited to, a formulation mixture of two vaccine constructs expressing antigens from each of the four serotypes (dengue 1, 2, 3 & 4), which are consistent with previous batches to ensure reproducibility of data generated between studies already carried out by investigators within the NMRC program. This notice of intent is not a request for competitive quotes. No solicitation document is available and telephone requests will not be accepted. However, any firm that determines it can meet the requirements may give written notice to the Contract Specialist within fifteen (15) calendar days from the date of publication of this synopsis. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirements. This information can be emailed to the Contract Specialist, contact@example.gov. Responses will be evaluated; however, a determination by the government not to compete the proposed procurement based upon responses to this notice is solely within the discretion of the government. This synopsis expires 21 July 2008 at 10:00 EST.